Latest European patent oppositions filed by Dorries, Hans Ulrich
| Patent Number | Title | Applicant | Opposition Date |
|---|---|---|---|
| EP4011915 | Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist | SANOFI BIOTECHNOLOGY | 2024-07-03 |
| EP3536712 | Methods For Reducing Lipoprotein(A) Levels By Administering An Inhibitor Of Proprotein Convertase Subtilisin Kexin-9 (Pcsk9) | REGENERON PHARMACEUTICALS, INC. | 2024-02-29 |
| EP3311168 | Novel Tnf Structure For Use In Therapy | UCB BIOPHARMA SRL | 2024-02-12 |
| EP3259593 | Homogenous Immunoassay With Compensation For Background Signal | IDEXX LABORATORIES, INC. | 2023-07-05 |
| EP2894165 | Methods And Compositions For Treating Complement-Associated Disorders | ALEXION PHARMACEUTICALS, INC. | 2023-05-17 |
| EP3590949 | Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses Thereof | MODERNATX, INC. | 2023-02-17 |
| EP3827845 | Subcutaneous Formulations Of Anti-Cd38 Antibodies And Their Uses | JANSSEN BIOTECH, INC. | 2022-12-22 |
| EP3157571 | Fatty Acids And Their Use In Conjugation To Biomolecules | NOVARTIS AG | 2022-08-24 |
| EP3209783 | Permanent Epigenetic Gene Silencing | FONDAZIONE TELETHON | 2022-08-24 |
| EP3470432 | Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist | SANOFI BIOTECHNOLOGY | 2022-07-05 |
Top clients of Dorries, Hans Ulrich filing patent oppositions